Medicare Payment Advisory Commission
Coverage of Medicare Payment Advisory Commission in the Nexus archive.
- The Trump administration is ending a Medicare drug subsidy program. Here’s how it could affect costs
The Trump administration is ending a Medicare drug subsidy program initiated by the Biden administration in 2024, leading to potential 2027 premium increases for 25 million Medicare Part D beneficiaries. Federal officials claim the impact will be minimal, with most seeing less than a $10-per-month increase, while Democrats criticize the move as increasing healthcare costs for seniors.
- The Trump administration is ending a Medicare drug subsidy program. Here's how it could affect costs
The Trump administration is ending a Medicare drug subsidy program that lowered prescription drug costs for 25 million seniors, leading to potential higher monthly premiums in 2027. The program, initially implemented by the Biden administration in 2024, was a response to the 2022 Inflation Reduction Act. Democrats criticized the decision as increasing costs for seniors, while CMS claims the impact will be minimal, with most beneficiaries seeing less than a $10 monthly increase.
- Opinion: The primary care crisis paradox
The Medicare Payment Advisory Commission (MedPAC) report shows primary care in America is succeeding, with nearly all Medicare beneficiaries having a primary care provider (PCP), over three-quarters seeing their PCP within two weeks, and rising compensation for PCPs. However, this data contradicts the common belief that increased investment in primary care is essential to solving the U.S. healthcare crisis.
- Medicare Should Pay Docs More, Cut Nursing Home and Home Health Pay, MedPAC Says
The Medicare Payment Advisory Commission (MedPAC) recommends increasing Medicare Physician Fee Schedule payments annually based on medical inflation while reducing payments for inpatient rehabilitation and home healthcare services.